Patrick S. Parfrey

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

Bruce F. Culleton, Martin G. Larson, Peter W.F. Wilson et al. · Kidney International · 1999 · 841 citations

Medicine, Nephrology, Preventive Cardiology +15

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt et al. · Kidney International · 2016 · 475 citations · Full text

Medicine, Hematology, Nephrology +17

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

Sharon M. Moe, Glenn M. Chertow, Patrick S. Parfrey et al. · Circulation · 2015 · 304 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis

Sharon M. Moe, Safa Abdalla, Glenn M. Chertow et al. · Journal of the American Society of Nephrology · 2014 · 210 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15